福岡脳卒中データベース研究 https://validator.w3.org/feed/docs/rss2.html FSR研究の成果が学会で発表されました FSR研究の成果が学会で発表されました Decreased Estimated Glomerular Filtration Rate and Proteinuria and Long-Term Outcomes After Ischemic Stroke: A Longitudinal Observational Cohort Study Association between abdominal adiposity and clinical outcomes in patients with acute ischemic stroke. Association between decreases in serum uric acid levels and unfavorable outcomes after ischemic stroke: A multicenter hospital-based observational study Predictive performance of machine learning–based models for poststroke clinical outcomes in comparison with conventional prognostic scores: multicenter, hospital-based observational study NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study. Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study. Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Proteinuria and clinical outcomes after ischemic stroke. Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry. Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese. Relationship between asian dust and ischemic stroke: a time-stratified case-crossover study. Risk factors predisposing to stroke recurrence within one year of non-cardioembolic stroke onset: the Fukuoka Stroke Registry. The factors associated with a functional outcome after ischemic stroke in diabetic patients: the Fukuoka Stroke Registry. Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry. RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke. Clinical significance of plasma VEGF value in ischemic stroke – research for biomarkers in ischemic stroke (REBIOS) study. Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry. Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry. The impact of predisposing factors on long-term outcome after stroke in diabetic patients: the Fukuoka Stroke Registry. Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry. Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke – Research for Biomarkers in Ischemic Stroke (REBIOS). ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry. Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke. Gastrointestinal bleeding in acute ischemic stroke: recent trends from the fukuoka stroke registry. Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry. Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry. Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation. Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study. Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke. Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry. Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke. Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry. Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation. Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke. Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm. Poor glycemic control and　posterior circulation ischemic stroke. Association Between Higher Insulin Resistance and Poor Short-Term Functional Outcome After Nonsurgical Intracerebral Hemorrhage. Impact of lean body mass index on short-term outcomes in patients with ischemic stroke: an observational cohort study. RNF213 p.R4810K Variant and Intracranial Atherosclerosis: Increased Risk in Obese Variant Carriers. FSR研究の成果が論文発表されました Secondary Prevention after Acute Ischemic Stroke: Antithrombotic Strategies and Prognostic Insights FSR研究の成果が学会で発表されました 現在行われている研究